Rakha EA, Reis-Filho JS, Sasano H, Wu Y. Neuroendocrine neoplasms: introduction. In: WHO classification of tumours editorial board. Breast tumours. WHO classification of tumours series. 5th ed. Lyon: IARC; 2019. p. 155.

Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31:1770–86.

PubMed  PubMed Central  Article  Google Scholar 

Wang J, Wei B, Albarracin CT, Hu J, Abraham SC, Wu Y. Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database. BMC Cancer. 2014;14:147.

PubMed  PubMed Central  Article  Google Scholar 

Roininen N, Takala S, Haapasaari KM, Jukkola-Vuorinen A, Mattson J, Heikkilä P, et al. Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study. BMC Cancer. 2017;17:72.

PubMed  PubMed Central  Article  Google Scholar 

Trevisi E, La Salvia A, Daniele L, Brizzi MP, De Rosa G, Scagliotti GV, et al. Neuroendocrine breast carcinoma: a rare but challenging entity. Med Oncol. 2020;37:70.

PubMed  PubMed Central  Article  Google Scholar 

Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, et al. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011;42:1169–77.

CAS  PubMed  Article  Google Scholar 

Zhang Y, Chen Z, Bao Y, Du Z, Li Q, Zhao Y, et al. Invasive neuroendocrine carcinoma of the breast: a prognostic research of 107 Chinese patients. Neoplasma. 2013;60:215–22.

CAS  PubMed  Article  Google Scholar 

Pareja F, Vahdatinia M, Marchio C, Lee SSK, Da Cruz Paula A, Derakhshan F, et al. Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites. J Clin Pathol. 2022;75:10–17.

CAS  PubMed  Article  Google Scholar 

Lavigne M, Menet E, Tille JC, Lae M, Fuhrmann L, Bonneau C, et al. Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast. Mod Pathol. 2018;31:68–82.

CAS  PubMed  Article  Google Scholar 

Marchiò C, Geyer FC, Ng CK, Piscuoglio S, De Filippo MR, Cupo M, et al. The genetic landscape of breast carcinomas with neuroendocrine differentiation. J Pathol. 2017;241:405–19.

PubMed  Article  CAS  Google Scholar 

Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, et al. Toward a shared vision for cancer genomic data. N Engl J Med. 2016;375:1109–12.

PubMed  PubMed Central  Article  Google Scholar 

Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 2017;543:65–71.

CAS  PubMed  Article  Google Scholar 

Brierley J, Gospodarowicz MK, Wittekind MKC. TNM classification of malignant tumours. Oxford; Wiley-Blackwell: 2017.

Karihtala P, Mäntyniemi A, Kang SW, Kinnula VL, Soini Y. Peroxiredoxins in breast carcinoma. Clin Cancer Res. 2003;9:3418–24.

CAS  PubMed  Google Scholar 

Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44:e71.

PubMed  Article  CAS  Google Scholar 

Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160–7.

PubMed  PubMed Central  Article  Google Scholar 

Martin M. CUTADAPT removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10–12.

Article  Google Scholar 

Andrews S. FastQC: a quality control tool for high throughput sequence data. 2010. http://www.bioinformatics.babraham.ac.uk/projects/fastqc. Accessed 21 Jan 2021.

Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26:589–95.

PubMed  PubMed Central  Article  CAS  Google Scholar 

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.

CAS  PubMed  PubMed Central  Article  Google Scholar 

1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature 2015;526:68–74.

Article  CAS  Google Scholar 

McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW, et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 2009;69:6660–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Carter H, Douville C, Stenson PD, Cooper DN, Karchin R. Identifying Mendelian disease genes with the variant effect scoring tool. BMC Genomics. 2013;14(Suppl 3):S3.

PubMed  PubMed Central  Article  Google Scholar 

Douville C, Carter H, Kim R, Niknafs N, Diekhans M, Stenson PD, et al. CRAVAT: cancer-related analysis of variants toolkit. Bioinformatics 2013;29:647–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kassambara A, Kosinski M, Biecek P. Survminer: drawing survival curves using “ggplot2”. R package version 0.4.8. 2013. https://CRAN.R-project.org/package=survminer Accessed 21 Jan 2021.

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300.

Google Scholar 

Therneau T. A package for survival analysis in R. R package version 3.2-7. 2020. https://CRAN.R-project.org/package=survival. Accessed 21 Jan 2021.

Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic signaling pathways in The Cancer Genome Atlas. Cell 2018;173:321–37.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747–56.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bergstrom EN, Huang MN, Mahto U, Barnes M, Stratton MR, Rozen SG, et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genomics. 2019;20:685.

PubMed  PubMed Central  Article  Google Scholar 

Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Shen JC, Rideout WM III, Jones PA. High frequency mutagenesis by a DNA methyltransferase. Cell. 1992;71:1073–80.

CAS  PubMed  Article  Google Scholar 

Ang D, Ballard M, Beadling C, Warrick A, Schilling A, O’Gara R, et al. Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets. Appl Immunohistochem Mol Morphol. 2015;23:97–103.

CAS  PubMed  Article  Google Scholar 

Costa RLB, Han HS, Gradishar WJ. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review. Breast Cancer Res Treat. 2018;169:397–406.

CAS  PubMed  Article  Google Scholar 

Regad T. Targeting RTK signaling pathways in cancer. Cancers (Basel). 2015;7:1758–84.

CAS  PubMed Central  Article  Google Scholar 

Yang Y, Li X, Wang T, Guo Q, Xi T, Zheng L. Emerging agents that target signaling pathways in cancer stem cells. J Hematol Oncol. 2020;13:60.

PubMed  PubMed Central  Article  Google Scholar 

Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Guo Y, Yu P, Liu Z, Maimaiti Y, Chen C, Zhang Y, et al. Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: a systematic review and meta-analysis. PLoS One. 2017;12:e0174843.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Takaku M, Grimm SA, De Kumar B, Bennett BD, Wade PA. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3. Nucleic Acids Res. 2020;48:4756–68.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gaynor KU, Grigorieva IV, Allen MD, Esapa CT, Head RA, Gopinath P, et al. GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness. Horm. Cancer 2013;4:123–39.

CAS  Google Scholar 

Acosta MJ, Vazquez Fonseca L, Desbats MA, Cerqua C, Zordan R, et al. Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta. 2016;1857:1079–85.

CAS